Menu Search
Equities

Medical Data Vision Co Ltd

MDVCF:PNK

Medical Data Vision Co Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Medical Data Vision Co Ltd grew revenues 5.15% from 6.10bn to 6.42bn while net income improved 12.48% from 870.51m to 979.13m.
Gross margin75.68%
Net profit margin-0.41%
Operating margin4.56%
Return on assets-0.47%
Return on equity0.13%
Return on investment-0.64%
More ▼

Cash flow in JPYView more

In 2023, Medical Data Vision Co Ltd increased its cash reserves by 42.09%, or 953.22m. The company earned 1.62bn from its operations for a Cash Flow Margin of 25.18%. In addition the company used 437.83m on investing activities and also paid 225.26m in financing cash flows.
Cash flow per share1.87
Price/Cash flow per share232.37
Book value per share97.57
Tangible book value per share95.71
More ▼

Balance sheet in JPYView more

Medical Data Vision Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio2.60
Quick ratio2.59
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in JPY

SmartText is unavailable
Div yield(5 year avg)0.33%
Div growth rate (5 year)--
Payout ratio (TTM)5,182.20%
EPS growth(5 years)71.34
EPS (TTM) vs
TTM 1 year ago		-99.36
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.